Home » Stocks » RSPI

RespireRx Pharmaceuticals, Inc. (RSPI)

Stock Price: $0.0372 USD -0.0007 (-1.85%)
Updated Apr 16, 2021 3:56 PM EDT - Market closed
Market Cap 2.40M
Revenue (ttm) n/a
Net Income (ttm) -5.74M
Shares Out 25.86M
EPS (ttm) -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $0.0372
Previous Close $0.0379
Change ($) -0.0007
Change (%) -1.85%
Day's Open 0.0370
Day's Range 0.0330 - 0.0450
Day's Volume 724,392
52-Week Range 0.0200 - 0.2230


Glen Rock, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company” or “we”), has been up listed from the OTC Pink Market and returns to the OTC...

Other stocks mentioned: RSPID
2 months ago - GlobeNewsWire

About RSPI

RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. It has two drug platforms comprising ResolutionRx, a pharmaceutical cannabinoids platform, which includes dronabinol that acts upon the nervous system's endogenous cannabinoid receptors for use in refractory chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS; and EndeavourRx, a neuromodulators platform that comprises AMPAkines program, inc... [Read more...]

Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

Financial Statements